( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )

Cantech Letter

The Very Best of Canadian Science and Technology

Main Content

latest…

HEXO Corp could be an acquisition target, Beacon Securities says

Analyst Russell Stanley of Beacon Securities has a number of reasons to be bullish about HEXO Corp … Keep reading

More recent headlines

See more stories

Cannabis

HEXO Corp could be an acquisition target, Beacon Securities says

By

Analyst Russell Stanley of Beacon Securities has a number of reasons to be bullish about HEXO Corp (HEXO Stock Quote, Chart TSX:HEXO), including its … Read More

See related

More Cannabis Articles

Invictus MD Interview

Stock Picks

BSM Technologies has a 154 per cent upside, Laurentian says

By

Ahead of the company's fourth quarter results, Laurentian Bank Securities analyst Nick Agostino thinks there is big upside in BSM Technologies (BSM … Read more

See related

See More Stock Picks

DMG Blockchain CEO interview

Life Sciences Stocks

Acerus Pharmaceuticals has a 364 per cent upside, Mackie Research says

By

Following what he describes as positive results from a Phase 1 study, Mackie Research Capital … Keep reading

Echelon Wealth Partners turns bullish on beaten down ProMetic Life Sciences

By

A new development for ProMetic Life Sciences (ProMetic Life Sciences Stock Quote, Chart TSX:PLI) has … Keep reading

Knight Therapeutics CEO Jonathan Goodman is a genius, this investor says

By

Specialty pharma company Knight Therapeutics (Knight Therapeutics Stock Quote, Chart TSX:GUD) has … Keep reading

IMV has 45 per cent upside, Echelon says

By

On its own, the potential of IMV Inc.’s (IMV Stock Quote, Chart TSX:IMV) cancer-fighting drug … Keep reading

Tetra Bio-Pharma financing a “sea-change” for the company, Paradigm Capital says

By

A new financing for Tetra Bio-Pharma (Tetra Bio-Pharma Stock Quote, Chart: TSXV:TBP) has Paradigm … Keep reading